ENTG Stock Overview
Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Entourage Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.03 |
| 52 Week Low | CA$0.01 |
| Beta | 1.21 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -60.00% |
| 3 Year Change | -96.72% |
| 5 Year Change | -99.47% |
| Change since IPO | -98.82% |
Recent News & Updates
Entourage Health Corp.'s (CVE:ENTG) Shares Leap 50% Yet They're Still Not Telling The Full Story
Apr 02
Entourage Health Corp. (CVE:ENTG) Soars 50% But It's A Story Of Risk Vs Reward
Feb 08Recent updates
Entourage Health Corp.'s (CVE:ENTG) Shares Leap 50% Yet They're Still Not Telling The Full Story
Apr 02Entourage Health Corp. (CVE:ENTG) Soars 50% But It's A Story Of Risk Vs Reward
Feb 08Not Many Are Piling Into Entourage Health Corp. (CVE:ENTG) Just Yet
Apr 19WeedMD Inc. (CVE:WMD) On The Verge Of Breaking Even
Jan 01
Shareholder Returns
| ENTG | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -8.9% | -1.5% |
| 1Y | -60.0% | 49.0% | 4.7% |
Return vs Industry: ENTG underperformed the Canadian Pharmaceuticals industry which returned 49% over the past year.
Return vs Market: ENTG underperformed the Canadian Market which returned 4.7% over the past year.
Price Volatility
| ENTG volatility | |
|---|---|
| ENTG Average Weekly Movement | 62.0% |
| Pharmaceuticals Industry Average Movement | 14.3% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: ENTG's share price has been volatile over the past 3 months.
Volatility Over Time: ENTG's weekly volatility has increased from 45% to 62% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | George Scorsis | entouragehealthcorp.com |
Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. It offers cannabis plants, dried flower, pre-rolls, soft chews, chewing gum, cannabis oils, capsules, topicals and vapes, extracts, and edibles. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Syndicate Cannabis, Mary’s Medicinals, and Irwin Naturals brand names.
Entourage Health Corp. Fundamentals Summary
| ENTG fundamental statistics | |
|---|---|
| Market cap | CA$4.63m |
| Earnings (TTM) | -CA$116.92m |
| Revenue (TTM) | CA$39.46m |
0.1x
P/S Ratio0.0x
P/E RatioIs ENTG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENTG income statement (TTM) | |
|---|---|
| Revenue | CA$39.46m |
| Cost of Revenue | CA$42.39m |
| Gross Profit | -CA$2.93m |
| Other Expenses | CA$113.99m |
| Earnings | -CA$116.92m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.38 |
| Gross Margin | -7.41% |
| Net Profit Margin | -296.29% |
| Debt/Equity Ratio | -118.9% |
How did ENTG perform over the long term?
See historical performance and comparison